By Daniel Niyongabo
NAIROBI, KENYA – The Bill & Melinda Gates Foundation has announced its largest ever commitment to women’s health research, pledging US$2.5 billion to combat what it describes as “needless suffering” and significantly improve health outcomes for women, particularly across Africa and other low- and middle-income countries.
The substantial funding aims to support over 40 innovations in chronically underfunded areas of women’s health. Bill Gates, co-chair of the foundation, underscored the critical link between the health of women and global economic prosperity. “Investing in women’s health has a lasting impact across generations,” Gates stated, emphasizing that “too many women still die from preventable causes or live in poor health,” a reality he insists must change.
The foundation’s funding will target five high-impact areas crucial for women’s lifespan: obstetric care and maternal immunization, maternal health and nutrition, gynecological and menstrual health, contraceptive innovation, and sexually transmitted infections. These priorities were identified through a combination of data, evidence, and direct insights gleaned from women in the affected regions themselves regarding their needs and preferences.
The announcement was met with strong endorsement from African health experts, who highlighted the continent’s disproportionate burden of women’s health challenges.
Professor Moses Obimbo Madadi, a Professor of Anatomy and Medical Physiology at the University of Nairobi, stressed the urgency of the new funding for African nations. “Sub-Saharan Africa, which accounts for a quarter of global births, accounted for more than 50% of women’s health-related challenges, including maternal mortality and associated morbidities,” Madadi explained. He revealed that in 2023 alone, approximately 182,000 women globally were lost due to pregnancy-related complications, with excessive bleeding after childbirth (postpartum hemorrhage) contributing to about 40% of these deaths.
Madadi, a recipient of the Gates Foundation’s Calestous Juma (CJ) Science Leadership Fellowship, praised the initiative. He is set to lead a coalition of researchers developing tools to study the “vaginal microbiome and metabolites” during pregnancy to identify interventions that can improve pregnancy outcomes in Kenya.
“We know that women’s health issues, especially where we come from, the low and middle-income countries, is really facing a staggering crisis,” Madadi said, pointing out that challenges span from adolescence through motherhood to menopause. He also highlighted neglected tropical diseases, non-communicable diseases like hypertension and gestational diabetes, gender-based violence, and harmful traditional practices as significant, yet often underfunded, threats to women’s health in the region. Preeclampsia, or hypertension during pregnancy, for instance, accounts for about 20% of maternal mortality in the region, despite being manageable with early diagnosis and treatment.
Dr. Anita Zaidi, head of the gender equality division at the Gates Foundation, elaborated on the funding strategy, stating the foundation intentionally chose areas that are both heavily burdened and historically underfunded. “What’s new is the focus, for example, on vaginal microbiome, on gynecological conditions such as heavy menstrual bleeding, which causes anemia,” Zaidi noted.
Professor Bosede Afolabi of the College of Medicine in Lagos echoed these sentiments, asserting that chronic under-investment in women’s health has led to “needless” suffering. She lauded the Gates Foundation’s commitment as a crucial recognition that “women’s lives, and the innovations that support them, must be prioritized everywhere.”
Addressing concerns about implementing innovations in low-resource, rural settings, particularly for obstetric care in Kenya, Dr. Zaidi pointed to the development of portable ultrasound technologies. While cost remains a barrier, the foundation is actively collaborating with manufacturers like Philips, GE, and Indian local producers to lower prices over the next two to three years. These portable devices could revolutionize primary care, allowing providers to quickly determine gestational age, identify multiple pregnancies, and assess placenta location, enabling crucial decisions about whether a mother can deliver safely in a local clinic or requires more advanced care.
The Gates Foundation is already collaborating with partners like Professor Madadi in Kenya to develop accessible diagnostic tools. Through metabolomics and artificial intelligence, Madadi’s team aims to predict high-risk pregnancies, including those leading to prematurity, stillbirths, or restricted fetal growth, allowing for earlier intervention and saving lives.
